| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:29870746 |
| GO:0000226 | Microtubule cytoskeleton organization | Decreases phenotype | PMID:29870746 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:24577723; PMID:25043952; PMID:27717697 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:37128655 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:23534466; PMID:8951241 |
| GO:0004679 | Amp-activated protein kinase activity | Decreases phenotype | PMID:34897960 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:23534466; PMID:33404196 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:37128655 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:33404196 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:33404196 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:23534466; PMID:8951241 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:27717697 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:23534466; PMID:23534466; PMID:27717697; PMID:29870746; PMID:24577723; PMID:25043952; PMID:27717697; PMID:29870746; PMID:29883672 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:27717697 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:21787718; PMID:23534466; PMID:24577723; PMID:25043952; PMID:29883672; PMID:8951241 |
| GO:0010823 | Negative regulation of mitochondrion organization | Increases phenotype | PMID:30605698 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:23534466; PMID:23534466; PMID:27717697; PMID:27717697; PMID:33404196 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:37128655 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:30605698 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:30605698; PMID:37128655 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:34897960 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:34897960; PMID:38294748 |
| GO:0036091 | Positive regulation of transcription from rna polymerase ii promoter in response to oxidative stress | Increases phenotype | PMID:29140578 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:21360559 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:29140578 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:38294748 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:30605698 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:29870746 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:34897960 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:29870746 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33404196 |
| GO:0046415 | Urate metabolic process | Affects phenotype | PMID:37128655 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:30605698 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:23534466; PMID:23534466; PMID:27717697; PMID:27717697 |
| GO:0055069 | Zinc ion homeostasis | Decreases phenotype | PMID:21360559 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:28347754; PMID:29883672 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:33404196 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:37128655 |
| GO:0071901 | Negative regulation of protein serine/threonine kinase activity | Affects phenotype | PMID:34897960 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:21787718; PMID:23534466; PMID:24933620 |
| GO:0097352 | Autophagosome maturation | Decreases phenotype | PMID:28347754 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:36347317 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:34897960 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:38294748 |
| GO:1902237 | Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | Increases phenotype | PMID:30605698 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:34897960 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27717697; PMID:27717697; PMID:28347754; PMID:28347754 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:36347317; PMID:38294748 |
| GO:1903917 | Positive regulation of endoplasmic reticulum stress-induced eif2 alpha dephosphorylation | Increases phenotype | PMID:30605698 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:30605698 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.